Roivant Sciences Ltd
F:87S

Watchlist Manager
Roivant Sciences Ltd Logo
Roivant Sciences Ltd
F:87S
Watchlist
Price: 10.85 EUR -8.71% Market Closed
Market Cap: 8B EUR
Have any thoughts about
Roivant Sciences Ltd?
Write Note

Roivant Sciences Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Roivant Sciences Ltd
Operating Income Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Roivant Sciences Ltd
F:87S
Operating Income
-$1.1B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Operating Income
-$171.3m
CAGR 3-Years
-154%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Operating Income
-$175.5m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Operating Income
-$196.5m
CAGR 3-Years
-45%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Operating Income
-ÂŁ59.6m
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Operating Income
ÂŁ54.2m
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
4%

See Also

What is Roivant Sciences Ltd's Operating Income?
Operating Income
-1.1B USD

Based on the financial report for Mar 31, 2024, Roivant Sciences Ltd's Operating Income amounts to -1.1B USD.

What is Roivant Sciences Ltd's Operating Income growth rate?
Operating Income CAGR 3Y
0%

Over the last year, the Operating Income growth was 8%.

Back to Top